Current Cancer Drug Targets
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 1
Author(s): G. S.W. Tsao
Affiliation:
Export Options
About this article
Cite this article as:
Tsao S.W. G., Meet Our Editorial Board Member, Current Cancer Drug Targets 2017; 17 (1) . https://dx.doi.org/10.2174/156800961701161202195944
DOI https://dx.doi.org/10.2174/156800961701161202195944 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
18
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Impact of the Emerging Genomics Data on the Management of Agerelated Phenotypes in the Context of Cellular Senescence
Current Drug Targets Iron Chelating Strategies in Systemic Metal Overload, Neurodegeneration and Cancer
Current Medicinal Chemistry Mesenchymal Stem Cells: An Emerging Tool for Cancer Targeting and Therapy
Current Stem Cell Research & Therapy Anti-Inflammatory Drugs and Prediction of New Structures by Comparative Analysis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
Endocrine, Metabolic & Immune Disorders - Drug Targets Chitin, Characteristic, Sources, and Biomedical Application
Current Pharmaceutical Biotechnology Addressing the Challenge: Current and Future Directions in Ovarian Cancer Therapy
Current Gene Therapy Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies
Current Cancer Drug Targets The Power of Matrix Factorization: Methods for Deconvoluting Genetic Heterogeneous Data at Expression Level
Current Bioinformatics The Need for Calcium Channels in Cell Proliferation
Recent Patents on Anti-Cancer Drug Discovery GRP78 Influences Chemoresistance and Prognosis in Cancer
Current Drug Targets Ribosome Display and Selection of Human Anti-Placental Growth Factor scFv Derived from Ovarian Cancer Patients
Protein & Peptide Letters Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy
Current Genomics Synthesis of New Dihydroquinopimaric Acid Analogs with Nitrile Groups as Apoptosis-Inducing Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Celecoxib and Dimethylcelecoxib Block Oxidative Phosphorylation, Epithelial-Mesenchymal Transition and Invasiveness in Breast Cancer Stem Cells
Current Medicinal Chemistry Therapeutic Potential of Autotaxin/Lysophospholipase D Inhibitors
Current Drug Targets DNA Damage Repair and Response Proteins as Targets for Cancer Therapy
Current Medicinal Chemistry Cetuximab: Its Use in Combination with Radiation Therapy and Chemotherapy in the Multimodality Treatment of Head and Neck Cancer
Recent Patents on Anti-Cancer Drug Discovery The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Current Cancer Drug Targets Comparison of High-Density Short Oligonucleotide Microarray Platforms
Current Bioinformatics